Cytomegalovirus-associated meningoradiculoneuritis after treatment of mantle cell lymphoma with a combination of chemotherapy and rituximab.
Vallet
S
S
Tempescul
A
A
Tran
A
A
Legrand-Quillien
M C
MC
Narbonne
V
V
Berthou
C
C
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000209:etiology; D006801:Humans; D016867:Immunocompromised Host; D020522:Lymphoma, Mantle-Cell / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008587:Meningitis, Viral / Q000150:complications* / Q000175:diagnosis; D008875:Middle Aged; D011843:Radiculopathy / Q000175:diagnosis / Q000209:etiology*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab